Report - INDACATEROL Long-Acting β2-Agonist for Treatment of COPDaf-lp.org/wp-content/uploads/2019/01/Onbrez-DR.-J.pdfQuoi de neuf dans la BPCO ? • Epidemiologie, en France –3,5 millions

Please pass captcha verification before submit form